Health Canada — Medical Devices · Canada · 2018-01-12 · Type III
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: Somagen Diagnostics along with Thermofisher Scientific would like to notify you of an urgent recall and backorder of ImmunoCAP Allergen c5, Ampicilloyl product code 14-4450-01 and ImmunoCAP Allergen c6, Amoxicilloyl product code 14-4451-01. An internal monitoring stability study has indicated that stability specifications have not been met and were in fact half the intended expiry date of 12 months. There is a possibility that samples with a low positive concentration may be incorrectly reported as negative. Any reported test results below the assay Limit of Qualification (LOQ) should be disregarded as these results may be invalid. No complaints or injuries to patients have been reported.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.